Galleries

With this divestment, Lonza plans to exit both softgels and liquid-filled hard capsules for the pharma market. (Lonza 	)
Pharma Deal

Lonza to Sell Two Production Sites to Nextpharma

Nextpharma will be acquiring two of Lonza’s production sites located in Ploermel, France and Edinburgh in the UK respectively. Both the sites produce liquid-filled hard capsules as well as softgels and with this deal Nextpharma intends to develop its technology for lipid based finished dosage forms.

Read on